About Papaya Enzyme
A proteolytic (cysteine-protease) enzyme from papaya latex (Carica papaya). Most established clinical use is topical wound debridement, not oral supplementation. Oral evidence is weak and almost entirely from multi-ingredient products: throat lozenges combining papain with lysozyme and bacitracin relieved sore-throat symptoms vs placebo, and an enzyme blend containing papain matched acyclovir for shingles pain — neither isolates papain's effect. Direct human evidence for digestion is limited and there are no meta-analyses. Safety note: can cause hypersensitivity/anaphylaxis, especially with papaya or latex allergy; the FDA withdrew prescription papain-urea topical products in 2008 over serious reactions. Activity is measured in USP/FCC papain units — mg dose alone does not reflect potency. Not an essential nutrient.
What Papaya Enzyme supports
- Proteolytic enzyme that breaks down protein
- Used in enzyme blends for digestion (limited standalone evidence)
How much Papaya Enzyme to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
100–500
mg
No standardized oral therapeutic dose; standalone capsules ~25–500 mg, studied up to ~1,200 mg. Potency is set by activity units (USP/FCC papain units), not mg — most labels list mg only. Usually appears in multi-enzyme blends.
Clinical evidence
Limited clinical evidence. Weak standalone oral evidence — mostly multi-ingredient lozenges/enzyme blends; main established use is topical debridement; no meta-analyses
Reference